A Randomised Phase II Trial of Temozolomide with or Without Cannabinoids in Patients with Recurrent Glioblastoma (ARISTOCRAT): Protocol for a Multi-Centre, Double-Blind, Placebo-Controlled Trial

Divyalakshmi Bhaskaran,Joshua Savage,Amit Patel,Fiona Collinson,Rhys Mant,Florien Boele,Lucy Brazil,Sara Meade,Peter Buckle,Siân Lax,Lucinda Billingham,Susan C. Short

BMC CANCER（2024）

Cited 3|Views21

Key words

Randomised phase II trial,Glioblastoma,Cannabinoids,Sativex,Nabiximols,Brain cancer,Tumour,Temozolomide,Progression free survival,Overall survival,Adverse events

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined